Inactive

Modification P00007 SPE2D220D0092 issued to invoke option year 4 for Lamotrigine ER National Contract. Modification P000006 SPE2D220D0092 to incorporate Drug Supply Chain Act (DSCA) into soliciation f... Modification P00007 SPE2D220D0092 issued to invoke option year 4 for Lamotrigine ER National Contract. Modification P000006 SPE2D220D0092 to incorporate Drug Supply Chain Act (DSCA) into soliciation for subject contract. Modification P00005 SPE2D220D0092 to incorporate FAR 52.204-27 Prohibition on a Bytedance covered Application (June 2023) into contract. Modification P00004 SPE2D220D0092 issued to invoke option year 3 for Lamotrigine ER National Contract. Modification P00003 SPE2D220D0092 issued to invoke option year 2 for Lamotrigine ER National Contract. Modification P00002 SPE2D220D0092 issued to invoke option year 1 for Lamotrigine ER National Contract. Modification P00001 SPE2D220D0092 is issued to incorporate FAR 52.204-24 and FAR 52.204-25 into subject solicitation. Amendment 0003 SPE2D220R0059 dated 02/14/2020 is issued to change the closing date to reflect February 25,2020 at 3:00 PM EST. Amendment 0002 SPE2D220R0059 dated 01/31/2020 is issued to correct the solicitation number on page four (4) of subject Request for Proposal Block 9: Submission Instructions to reflect Solicitation Number: SPE2D2-20-R-0059 I/L/L SPE2D2-19-R-0059. Amendment 0001 SPE2D220R0059 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation. Solicitation for Lamotrigine ER Tablets SPE2D220R0059.

Inactive

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Lamotrigine ER. Procurement details follow. Lamotrigine ER 24 in 25MG, 50MG, 100MG, 200MG, 250... The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Lamotrigine ER. Procurement details follow. Lamotrigine ER 24 in 25MG, 50MG, 100MG, 200MG, 250MG and 300MG Tablets in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual estimated usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Phyllis Daraio (215-737-7941) email phyllis.daraio@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is January of 2020. DLA reserves the right to issue the solicitation before or after the projected solicitation date.